vs
DOMO, INC.（DOMO）与帕可Bio（PACB）财务数据对比。点击上方公司名可切换其他公司
DOMO, INC.的季度营收约是帕可Bio的1.8倍（$79.4M vs $44.6M），DOMO, INC.净利率更高（-13.1% vs -90.4%，领先77.3%），帕可Bio同比增速更快（13.8% vs -0.5%），DOMO, INC.自由现金流更多（$1.1M vs $-19.9M），过去两年帕可Bio的营收复合增速更高（7.3% vs -0.5%）
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业，主营人工智能、商业智能与数据可视化业务，属于SaaS（软件即服务）企业，核心产品可帮助企业各层级决策者在极少IT介入的情况下，实时获取业务数据，支撑决策开展。
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
DOMO vs PACB — 直观对比
营收规模更大
DOMO
是对方的1.8倍
$44.6M
营收增速更快
PACB
高出14.3%
-0.5%
净利率更高
DOMO
高出77.3%
-90.4%
自由现金流更多
DOMO
多$21.0M
$-19.9M
两年增速更快
PACB
近两年复合增速
-0.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $44.6M |
| 净利润 | $-10.4M | $-40.4M |
| 毛利率 | 74.2% | 37.1% |
| 营业利润率 | -8.7% | -92.3% |
| 净利率 | -13.1% | -90.4% |
| 营收同比 | -0.5% | 13.8% |
| 净利润同比 | 44.6% | -1802.7% |
| 每股收益（稀释后） | $-0.25 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMOPACB
| Q4 25 | $79.4M | $44.6M | ||
| Q3 25 | $79.7M | $38.4M | ||
| Q2 25 | $80.1M | $39.8M | ||
| Q1 25 | $78.8M | $37.2M | ||
| Q4 24 | $79.8M | $39.2M | ||
| Q3 24 | $78.4M | $40.0M | ||
| Q2 24 | $80.1M | $36.0M | ||
| Q1 24 | $80.2M | $38.8M |
净利润DOMOPACB
| Q4 25 | $-10.4M | $-40.4M | ||
| Q3 25 | $-22.9M | $-38.0M | ||
| Q2 25 | $-18.1M | $-41.9M | ||
| Q1 25 | $-17.7M | $-426.1M | ||
| Q4 24 | $-18.8M | $2.4M | ||
| Q3 24 | $-19.5M | $-60.7M | ||
| Q2 24 | $-26.0M | $-173.3M | ||
| Q1 24 | $-18.7M | $-78.2M |
毛利率DOMOPACB
| Q4 25 | 74.2% | 37.1% | ||
| Q3 25 | 74.8% | 41.4% | ||
| Q2 25 | 74.2% | 36.9% | ||
| Q1 25 | 74.4% | -3.7% | ||
| Q4 24 | 75.0% | 25.6% | ||
| Q3 24 | 74.3% | 25.0% | ||
| Q2 24 | 74.1% | 16.5% | ||
| Q1 24 | 76.3% | 29.1% |
营业利润率DOMOPACB
| Q4 25 | -8.7% | -92.3% | ||
| Q3 25 | -9.1% | -101.1% | ||
| Q2 25 | -17.9% | -112.8% | ||
| Q1 25 | -15.6% | -1154.5% | ||
| Q4 24 | -13.9% | -390.1% | ||
| Q3 24 | -18.5% | -160.3% | ||
| Q2 24 | -26.8% | -488.3% | ||
| Q1 24 | -16.6% | -209.6% |
净利率DOMOPACB
| Q4 25 | -13.1% | -90.4% | ||
| Q3 25 | -28.8% | -98.9% | ||
| Q2 25 | -22.5% | -105.4% | ||
| Q1 25 | -22.4% | -1146.8% | ||
| Q4 24 | -23.5% | 6.0% | ||
| Q3 24 | -24.9% | -151.9% | ||
| Q2 24 | -32.5% | -481.3% | ||
| Q1 24 | -23.3% | -201.4% |
每股收益（稀释后）DOMOPACB
| Q4 25 | $-0.25 | $-0.11 | ||
| Q3 25 | $-0.56 | $-0.13 | ||
| Q2 25 | $-0.45 | $-0.14 | ||
| Q1 25 | $-0.45 | $-1.44 | ||
| Q4 24 | $-0.48 | $-0.44 | ||
| Q3 24 | $-0.51 | $-0.22 | ||
| Q2 24 | $-0.69 | $-0.64 | ||
| Q1 24 | $-0.51 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $279.5M |
| 总债务越低越好 | $124.2M | — |
| 股东权益账面价值 | $-191.9M | $5.3M |
| 总资产 | $201.6M | $784.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMOPACB
| Q4 25 | — | $279.5M | ||
| Q3 25 | — | $298.7M | ||
| Q2 25 | $47.2M | $314.7M | ||
| Q1 25 | $45.3M | $343.1M | ||
| Q4 24 | — | $389.9M | ||
| Q3 24 | — | $471.1M | ||
| Q2 24 | $61.2M | $509.8M | ||
| Q1 24 | $60.9M | $561.9M |
总债务DOMOPACB
| Q4 25 | $124.2M | — | ||
| Q3 25 | $121.9M | — | ||
| Q2 25 | $119.7M | — | ||
| Q1 25 | $117.7M | — | ||
| Q4 24 | $115.6M | — | ||
| Q3 24 | $115.2M | — | ||
| Q2 24 | $114.1M | — | ||
| Q1 24 | $113.5M | — |
股东权益DOMOPACB
| Q4 25 | $-191.9M | $5.3M | ||
| Q3 25 | $-191.5M | $36.1M | ||
| Q2 25 | $-178.7M | $61.5M | ||
| Q1 25 | $-177.2M | $91.6M | ||
| Q4 24 | $-171.2M | $506.6M | ||
| Q3 24 | $-166.4M | $453.1M | ||
| Q2 24 | $-163.5M | $492.7M | ||
| Q1 24 | $-153.5M | $649.0M |
总资产DOMOPACB
| Q4 25 | $201.6M | $784.1M | ||
| Q3 25 | $195.7M | $803.2M | ||
| Q2 25 | $189.7M | $825.5M | ||
| Q1 25 | $214.3M | $860.8M | ||
| Q4 24 | $190.2M | $1.3B | ||
| Q3 24 | $197.8M | $1.5B | ||
| Q2 24 | $204.4M | $1.5B | ||
| Q1 24 | $225.7M | $1.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.4M | $-19.1M |
| 自由现金流经营现金流 - 资本支出 | $1.1M | $-19.9M |
| 自由现金流率自由现金流/营收 | 1.4% | -44.6% |
| 资本支出强度资本支出/营收 | 2.9% | 1.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $9.9M | $-114.1M |
8季度趋势，按日历期对齐
经营现金流DOMOPACB
| Q4 25 | $3.4M | $-19.1M | ||
| Q3 25 | $3.4M | $-18.7M | ||
| Q2 25 | $4.0M | $-29.4M | ||
| Q1 25 | $8.9M | $-44.1M | ||
| Q4 24 | $-13.7M | $-30.6M | ||
| Q3 24 | $-6.2M | $-45.5M | ||
| Q2 24 | $1.9M | $-54.3M | ||
| Q1 24 | $5.4M | $-75.7M |
自由现金流DOMOPACB
| Q4 25 | $1.1M | $-19.9M | ||
| Q3 25 | $1.0M | $-18.8M | ||
| Q2 25 | $1.0M | $-29.9M | ||
| Q1 25 | $6.7M | $-45.4M | ||
| Q4 24 | $-16.2M | $-32.3M | ||
| Q3 24 | $-8.4M | $-46.3M | ||
| Q2 24 | $-625.0K | $-55.7M | ||
| Q1 24 | $2.9M | $-79.6M |
自由现金流率DOMOPACB
| Q4 25 | 1.4% | -44.6% | ||
| Q3 25 | 1.3% | -48.9% | ||
| Q2 25 | 1.3% | -75.3% | ||
| Q1 25 | 8.5% | -122.3% | ||
| Q4 24 | -20.3% | -82.3% | ||
| Q3 24 | -10.7% | -115.7% | ||
| Q2 24 | -0.8% | -154.8% | ||
| Q1 24 | 3.6% | -205.0% |
资本支出强度DOMOPACB
| Q4 25 | 2.9% | 1.9% | ||
| Q3 25 | 2.9% | 0.2% | ||
| Q2 25 | 3.7% | 1.4% | ||
| Q1 25 | 2.8% | 3.7% | ||
| Q4 24 | 3.2% | 4.1% | ||
| Q3 24 | 2.8% | 2.0% | ||
| Q2 24 | 3.2% | 4.1% | ||
| Q1 24 | 3.1% | 10.0% |
现金转化率DOMOPACB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -12.93× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
